Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
23Strands logo — 23Strands is unlocking the power of your DNA

23Strands

23Strands is unlocking the power of your DNA

Founded 2018 Australia Australia 15 employees Seed Total: $10.00K AI, Big Data +3

General Information

Company Name 23Strands
Founded Year 2018
Location Australia Australia
Employees 15
Industries AI, Big Data, Biotechnology +2
Funding Stage Seed
Business Model B2B, D2C, SaaS
Revenue Model Subscription, Service Fee, Tiered Pricing
Offices as of Nov 2026
AU NSW Pyrmont 2009, AU NSW Pyrmont 2009 AU Victoria Melbourne 3000, AU Victoria Melbourne 3000
Social

BounceWatch is an independent company data service, not affiliated with 23Strands. To contact 23Strands, visit 23strands.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does 23Strands compare?

A PDF of 23Strands and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting 23Strands soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About 23Strands

23Strands, with its slogan "23Strands is unlocking the power of your DNA," is an Australia-based startup leveraging advancements in AI, Big Data, Biotechnology, Health Care, and Machine Learning to innovate in the realm of genetic analysis.

Founded in 2018, the company aims to redefine Whole Human Genome Sequencing (WHGS) by integrating clinical insights with medical records through Artificial Intelligence. This approach seeks to empower specialists, general practitioners, and patients by providing evidence-based healthcare recommendations.

Their technology capitalizes on big data processing breakthroughs to deliver trustworthy insights for improving long-term health outcomes.

The company's most recent financial activity was a $10.00K seed investment dated 01 September 2020, sourced from the 10x Accelerator - UNSW.

Business keywords: Whole Human Genome Sequencing, Genomics, Integrated Medical Records, Health Improvements, Clinical Insights, Big Data Processing, Evidence-based Recommendations, Personalized Medicine, Disease Risk Assessment, Medication Optimization, Healthcare Innovation, Genetic Testing, DNA Analysis

Services & Products

Whole Genome Sequencing
Genomic Health Analysis
Fertility23 Program
Medical Record Integration
Precision Health Insights
Concierge Health Pathway

Target Customers

Clinicians Healthcare Providers Patients with Unexplained Infertility Reproductive Health Specialists Medical Researchers

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed $10.00K 1
10x Accelerator - UNSW
01 Sep 2020

23Strands Alternatives & Competitors

View All Alternatives
23Strands vs
Congenica
Congenica United Kingdom

Driving Precision Medicine

Acquired
23 employees
Biotechnology, Health Care
23Strands vs
Mendelics
Mendelics Brazil

Análise genômica ao alcance de todos

154 employees
Biotechnology, Health Care
23Strands vs
54gene
54gene Nigeria

Equalizing Precision Medicine

112 employees
Biotechnology, Health Care
View all alternatives

FAQ About 23Strands

23Strands is unlocking the power of your DNA
23Strands was founded in 2018.
23Strands is headquartered in Australia. As of Nov 2026, it also has offices in AU NSW Pyrmont 2009, AU NSW Pyrmont 2009 and AU Victoria Melbourne 3000, AU Victoria Melbourne 3000.
23Strands operates in AI, Big Data, Biotechnology, Health Care and Machine Learning. Its work centres on Whole Human Genome Sequencing, Genomics, Integrated Medical Records and Health Improvements. Its customers include Clinicians, Healthcare Providers and Patients with Unexplained Infertility.
23Strands has a B2B, D2C and SaaS business model. Its revenue comes from Subscription, Service Fee and Tiered Pricing.
23Strands has approximately 15 employees.
23Strands has completed 1 funding round, raising a total of $10.00K. The latest funding stage is Seed.
23Strands offers: Whole Genome Sequencing, Genomic Health Analysis, Fertility23 Program, Medical Record Integration, Precision Health Insights, Concierge Health Pathway.
Top alternatives and competitors to 23Strands include Congenica, Mendelics, 54gene, Vitagene, CENTOGENE. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
23Strands and Congenica are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for 23Strands, https://bouncewatch.com/company/23strands, updated 5 November 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout